Purpose: to describe nurses' perceptions of using play in a pediatric onco-hematology setting.

Design And Methods: A qualitative descriptive study was conducted in the pediatric onco-hematology department of a tertiary hospital in northern Italy. Eleven nurses working in the involved department were recruited via convenience sampling. Data were gathered through face-to-face interviews using a semi-structured guide. Data were analyzed using a descriptive qualitative approach.

Results: Four major themes emerged from the analysis: 1) The different purposes in using play, 2) A matter of time, 3) Choosing the most suitable game, and 4) Sharing celebrative moments as moments of interprofessional development. Nurses described play as a means to build trust, relieve parents, serve as an educational tool, and address children's needs. Although nurses recognized the limited time available, they wanted to manage their workload to accommodate play. They emphasized the importance of choosing suitable games and using playful moments as opportunities for fun and professional growth.

Conclusions: Therapeutic play should be systematically integrated into pediatric oncology care as it fosters trust, provides joy and relief, and supports the child and their parents.

Practice Implications: Play should be incorporated into routine practice, ensuring children can access peer interaction and age-appropriate games. A multidisciplinary approach, with the involvement of trained professionals, should be fostered to support play-based care in pediatric oncology settings.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pedn.2024.10.031DOI Listing

Publication Analysis

Top Keywords

onco-hematology department
8
pediatric onco-hematology
8
choosing suitable
8
pediatric oncology
8
play
7
nurses' perspectives
4
perspectives role
4
role play
4
play children
4
children onco-hematology
4

Similar Publications

Outcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patients.

ESMO Open

January 2025

Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy; Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende, Italy. Electronic address:

Background: Daratumumab-refractory multiple myeloma (Dara-R MM) presents a significant treatment challenge. This study aimed to evaluate the efficacy and survival outcomes of elotuzumab, pomalidomide, and dexamethasone (EloPd) in a large, real-world cohort of patients with Dara-R MM, with particular focus on progression-free survival (PFS) and overall survival (OS).

Materials And Methods: This retrospective analysis included 247 Dara-R MM patients treated with EloPd.

View Article and Find Full Text PDF

Inherited factor VII deficiency is the most common rare bleeding disorder, affecting about 1/500,000 individuals without gender predilection. Most of the patients with FVII 20-50% are asymptomatic, but post-traumatic or post-surgical bleeding may often occur since there is not an exact correlation between FVII plasma levels and the bleeding phenotype. We enrolled 19 children and adolescents with FVII levels of 20-35% and 33 controls.

View Article and Find Full Text PDF

Background: Anaplastic lymphoma kinase (ALK) plays a role in the development of lymphoma, lung cancer and neuroblastoma. While tyrosine kinase inhibitors (TKIs) have improved treatment outcomes, relapse remains a challenge due to on-target mutations and off-target resistance mechanisms. ALK-positive (ALK+) tumors can evade the immune system, partly through tumor-associated macrophages (TAMs) that facilitate immune escape.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!